NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest (ARCB) Q3 EPS Rebound Tests Bearish Margin Narrative

ArcBest FY 2025 earnings snapshot ArcBest (ARCB) has put another data point on the board for FY 2025, with Q3 revenue of US$1,048.1 million and basic EPS of US$1.73, supported by net income of US$39.3 million. The company has seen quarterly revenue move from US$1,077.8 million in Q2 2024 to US$1,001.6 million in Q4 2024 and then to US$967.1 million, US$1,022.3 million and US$1,048.1 million through the first three quarters of 2025, while EPS has ranged from US$1.99 to US$0.13 and up to...
NYSE:HPQ
NYSE:HPQTech

How Investors Are Reacting To HP (HPQ) Dividend Payout As Greenlight Capital Exits Over AI PC Risks

HP Inc. recently declared a US$0.30 per-share cash dividend, its second in fiscal 2026, payable on April 1, 2026, to shareholders of record as of March 11, 2026, while managing approximately 0.90 billion common shares outstanding. A contrasting development came as Greenlight Capital exited its HP position with a small gain, publicly flagging rising memory costs and muted AI-driven PC demand as key business risks for the company. Against this backdrop, we’ll examine how Greenlight Capital’s...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

LPL Financial (LPLA) Margin Compression Challenges Bullish Growth Narrative After FY 2025 Results

LPL Financial Holdings (LPLA) just wrapped up FY 2025 with Q4 revenue of US$4.8 billion and basic EPS of US$3.76, alongside net income of US$300.7 million. This puts fresh numbers on the table for investors tracking its full year. The company has seen quarterly revenue move from US$3.4 billion in Q4 2024 to US$4.8 billion in Q4 2025, with basic EPS shifting from US$3.62 to US$3.76 over the same stretch, while trailing 12 month revenue sits at US$16.6 billion and EPS at US$10.97. Margins are...
NasdaqGS:GSIT
NasdaqGS:GSITSemiconductor

GSI Technology (GSIT) Premium P/S And Ongoing Losses Test Bullish Narratives Ahead Of Q3 2026

GSI Technology (GSIT) has just posted its Q3 2026 scorecard, with recent quarters showing revenue around US$6.4 million in Q2 2026 and a basic EPS loss of US$0.11, while the trailing twelve months reflect a basic EPS loss of US$0.43 and net income losses of US$11.66 million. Over the past six reported quarters, revenue has moved from US$4.55 million in Q2 2025 to US$6.44 million in Q2 2026, while basic EPS has ranged from a profit of US$0.04 in Q1 2025 to losses between US$0.08 and US$0.21...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Hires Omkar Joshi To Drive Tech Efficiency And Unlock Valuation Gap

Healthpeak Properties (NYSE:DOC) has appointed Omkar Joshi as Head of Enterprise Innovation. Joshi, a former Palantir executive, will lead technology, automation, and data initiatives across the company. The move signals a stronger push toward digital transformation and operational efficiency at Healthpeak Properties. Healthpeak Properties, trading at $17.24, has seen mixed share performance, with a 7.2% return over the past 30 days and a 6.4% return year to date, alongside a 10.3% decline...
NasdaqGS:RRBI
NasdaqGS:RRBIBanks

Net Interest Margin Expansion At Red River Bancshares (RRBI) Tests Bullish Earnings Narratives

Red River Bancshares (RRBI) just posted its FY 2025 third quarter numbers, reporting total revenue of US$31.3 million and basic EPS of US$1.63, supported by net income of US$10.8 million. The company has seen quarterly revenue move from US$27.6 million in Q3 2024 to US$31.3 million in Q3 2025, while basic EPS has gone from US$1.28 to US$1.63 over the same period, with trailing twelve month EPS at US$6.04 and net income at US$40.7 million. With a trailing net profit margin of 34.1% and a...
NYSE:PHM
NYSE:PHMConsumer Durables

Is It Time To Reconsider PulteGroup (PHM) After Strong Multi Year Share Gains?

If you are wondering whether PulteGroup's current share price still offers value, you are not alone. The stock has attracted a lot of attention from investors checking if the homebuilder is priced fairly. PulteGroup's share price last closed at US$125.09, with returns of negative 0.1% over 7 days, 6.7% over 30 days, 5.1% year to date, 10.8% over 1 year and a very large gain over 3 and 5 years. Recent coverage has focused on PulteGroup within the US homebuilding sector, as investors track how...
NasdaqGS:HNVR
NasdaqGS:HNVRBanks

Hanover Bancorp (HNVR) Cost Efficiency Rebound Challenges Bearish Margin Narratives

Hanover Bancorp (HNVR) has laid out its FY 2025 scorecard with fiscal third quarter revenue of US$16.7 million and EPS of US$0.47, alongside trailing twelve month revenue of US$68.0 million and EPS of US$1.52, giving investors a clear read on recent earnings power. Over the past year, the company has seen revenue move from US$59.8 million to US$68.0 million on a trailing basis, while trailing EPS shifted from US$1.66 to US$1.52. This sets the backdrop for a conversation about how its 16.2%...
NYSE:ECL
NYSE:ECLChemicals

Ecolab Weighs Digital Growth Against Tariff Pressures And Valuation Premium

Ecolab (NYSE:ECL) is reporting strong momentum in its Digital and Global High-Tech segments. These technology focused businesses are expanding even as the company faces tariff related inflation and softer demand in some areas. The mix of growth in high tech offerings and external cost pressures is a key theme for investors tracking Ecolab's next phase. Ecolab, trading at $281.99, is putting more weight behind its digital and high tech solutions at a time when parts of its portfolio are...
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

MetroCity Bankshares (MCBS) Net Margin Strength Reinforces Bullish Profitability Narratives

MetroCity Bankshares (MCBS) has reported Q3 FY 2025 results with total revenue of US$38.5 million and basic EPS of US$0.68, alongside net income of US$17.3 million, giving investors a fresh read on the bank’s earnings power. The company has seen trailing twelve month revenue shift from US$126.4 million in Q2 2024 to US$147.3 million in Q3 2025, with EPS over that same trailing window moving from US$2.15 to US$2.62. This sets up a results season where margins and earnings quality are front of...
NasdaqGS:UTMD
NasdaqGS:UTMDMedical Equipment

Utah Medical Products (UTMD) Margin Decline Challenges Steady Compounder Narrative

Utah Medical Products (UTMD) closed FY 2025 with Q4 revenue of US$9.0 million and basic EPS of US$0.80, setting the tone for a year where earnings and sales moved within a relatively tight range. Over the past six quarters, quarterly revenue has run between US$9.0 million and US$10.0 million while basic EPS has ranged from about US$0.80 to US$1.02. This gives investors a clear look at how top line and EPS have tracked together through FY 2024 into FY 2025. With trailing net margins easing and...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

Did 53.60% Revenue Growth and Portfolio Expansion Just Shift ANI Pharmaceuticals' (ANIP) Investment Narrative?

ANI Pharmaceuticals recently reported revenue growth of 53.60% and continues to broaden its product portfolio and distribution channels, drawing strong interest from analysts and investors alike. With seven buy ratings and widespread optimism about its expanding business footprint, the company’s position within the pharmaceutical sector is gaining increased attention. Next, we’ll examine how ANI Pharmaceuticals’ rapid revenue growth shapes its investment narrative and what it could mean for...
NasdaqCM:RBKB
NasdaqCM:RBKBBanks

Rhinebeck Bancorp (RBKB) Net Interest Margin Recovery Challenges Multi Year Earnings Decline Narrative

Rhinebeck Bancorp (RBKB) has just posted its FY 2025 numbers, with fourth quarter revenue of US$13.0 million and EPS of US$0.22, while over the trailing twelve months revenue came in at US$51.7 million and EPS reached US$0.93. The company has seen revenue move from US$25.9 million and an EPS loss of US$0.80 over the trailing year to Q4 2024 to US$51.7 million and EPS of US$0.93 over the latest trailing period, giving investors a clear set of revenue and EPS figures to weigh. With a net...
NYSE:FLG
NYSE:FLGBanks

Flagstar Bank Q3 Loss Narrows Yet Keeps Bearish Profitability Narratives In Play

Flagstar Bank National Association (FLG) has just posted another loss for Q3 2025, reporting total revenue of US$481 million and a net loss of US$45 million, or EPS of US$0.11. This keeps the full year firmly in loss making territory so far. Over recent periods the bank has seen revenue move from US$281 million in Q2 2024 to US$381 million in Q3 2024, then to US$480 million in Q4 2024, and US$411 million, US$432 million and US$481 million across Q1 to Q3 2025. Quarterly EPS has ranged between...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical (EMN) Margin Compression Challenges Bullish Earnings Growth Narrative

How Eastman Chemical's FY 2025 Numbers Set Up the Next Part of the Story Eastman Chemical (EMN) has wrapped up FY 2025 with fourth quarter revenue of US$1,973 million, Basic EPS of US$0.92 and net income excluding extraordinary items of US$105 million. The trailing twelve months show revenue of US$8.75 billion, Basic EPS of US$4.13 and net income of US$474 million. Over the past few quarters, the company has reported revenue moving from US$2,464 million in Q3 2024 to US$1,973 million in Q4...
NasdaqGS:KC
NasdaqGS:KCIT

Assessing Kingsoft Cloud (KC) Valuation After Revenue Progress And Upgraded Xingliu AI Platform

Kingsoft Cloud Holdings (KC) is back on traders’ screens after a mix of operational updates, including year over year revenue growth, a narrower GAAP loss, and an upgraded Xingliu AI platform with expanded training, inference, and robotics capabilities. See our latest analysis for Kingsoft Cloud Holdings. The recent Xingliu AI upgrade and RSU grants have come against a backdrop of strong short term momentum, with a 30 day share price return of 27.76% and a year to date share price return of...
NYSE:CVS
NYSE:CVSHealthcare

CVS Health (CVS) Is Down 10.2% After Surprise CMS Medicare Advantage Rate Proposal - Has The Bull Case Changed?

Earlier this week, the Centers for Medicare & Medicaid Services proposed a near-flat 2027 payment increase for Medicare Advantage plans, well below industry expectations and raising concerns about revenue pressure for insurers such as CVS Health. Alongside the modest rate proposal, CMS suggested risk-score and billing changes that could further affect how CVS’s Aetna business is reimbursed for Medicare Advantage members. We’ll now examine how this unexpectedly small Medicare Advantage rate...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Do Allegiant’s Rising Traffic Metrics Reframe Its Long-Term Margin Story for Investors (ALGT)?

Allegiant Travel Company recently reported its December, fourth-quarter, and full-year 2025 operating statistics, showing year-on-year increases in passengers, available seat miles, and revenue passenger miles, with load factors broadly stable despite slight full-year softening. The company also set a February 4, 2026 conference call to discuss its fourth-quarter and full-year 2025 financial results, signaling that management will soon frame these traffic trends within a broader financial...
NYSE:MMI
NYSE:MMIReal Estate

A Look At Marcus & Millichap (MMI) Valuation After Recent Share Price Momentum

Event context and recent stock performance Marcus & Millichap (MMI) has been drawing investor attention after recent share price moves, with the stock up about 0.8% over the past day and 2.5% over the past week. Those gains contrast with a small decline over the past month and a roughly 6.9% decline over the past 3 months, raising questions about how short term momentum lines up with the company’s underlying fundamentals. See our latest analysis for Marcus & Millichap. Stepping back, the...
NYSE:FR
NYSE:FRIndustrial REITs

How Investors May Respond To First Industrial Realty Trust (FR) Extending And Amending Key Term Loans

On January 22, 2026, First Industrial Realty Trust refinanced and amended its major unsecured term loans, extending maturities into 2029 and 2030, expanding capacity on one facility to US$375 million, and removing a 10 basis point SOFR adjustment while keeping the loans interest-only. The revised agreements also introduce potential sustainability-linked pricing and tighten covenant structures, reshaping the REIT’s funding profile and flexibility for future capital allocation decisions. Next,...
NYSE:RAL
NYSE:RALElectronic

Is It Time To Reconsider Ralliant (RAL) After Recent Tech Partnership Updates?

If you are wondering whether Ralliant's current share price gives you good value for your money, you are not alone. This article is built to help you assess that. Over the short term, the stock has seen a 1.4% decline over the past week, a 4.0% gain over the last 30 days and a 3.4% return year to date, which has likely caught the attention of investors tracking short term moves. Recent coverage has focused on Ralliant's position in the tech sector and how investors are reacting to its latest...
NYSE:CHD
NYSE:CHDHousehold Products

Church And Dwight Q3 Margins And EPS Support Bullish Profitability Narratives

Church & Dwight (CHD) just posted its FY 2025 third quarter numbers, with revenue of US$1,585.6 million and basic EPS of US$0.75, alongside net income of US$182.2 million. The company has seen quarterly revenue move from US$1,511.2 million in Q2 2024 to US$1,582.0 million in Q4 2024 and then to US$1,585.6 million in Q3 2025. Over the same periods, basic EPS shifted from US$1.00 to US$0.77 and then to US$0.75, creating a picture in which the headline growth story is now as much about how...
NYSE:B
NYSE:BMetals and Mining

Assessing Barrick Mining (NYSE:B) Valuation After A Strong Year And Recent Share Price Pullback

Why Barrick Mining is on investors’ radar today Barrick Mining (NYSE:B) is drawing attention after a year in which its total return sits around 186%, alongside recent one day and past week share price declines that may have some investors reassessing their timing. See our latest analysis for Barrick Mining. The recent 1 day and 7 day share price returns of 12.03% and 10.36% declines contrast with a 39.60% 90 day share price return and a 1 year total shareholder return of 185.63%. This...
NYSE:BRO
NYSE:BROInsurance

Why Brown & Brown (BRO) Is Down 8.9% After Slower Organic Growth Despite Higher 2025 Earnings – And What's Next

Brown & Brown, Inc. recently reported full-year 2025 results, with revenue rising to US$5.90 billion and net income reaching US$1.05 billion, while also declaring a regular quarterly dividend of US$0.165 per share payable on February 11, 2026. The mixed quarter highlighted rising adjusted earnings alongside a revenue shortfall and weaker organic growth, all against the backdrop of integrating its largest-ever acquisition and managing leadership changes following the passing of its Chief...